# Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

> **NCT00212862** · — · COMPLETED · sponsor: **Ortho Biotech Products, L.P.** · enrollment: 2130 (actual)

## Conditions studied

- Anemia
- Cancer

## Interventions

- **OTHER:** Patients with chemotherapy induced anemia

## Key facts

- **NCT ID:** NCT00212862
- **Lead sponsor:** Ortho Biotech Products, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 2130 (ACTUAL)
- **Last updated:** 2014-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212862, "Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00212862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*